Altamira Therapeutics Ltd. - Common Shares (CYTO)

Altamira Therapeutics Ltd is a biopharmaceutical company focused on developing innovative therapies for neurological and other serious conditions

The company leverages its proprietary technology platforms to create treatments that enhance drug delivery and optimize patient outcomes. With a commitment to addressing unmet medical needs, Altamira is engaged in advancing its product candidates through various stages of preclinical and clinical development, aiming to provide new therapeutic options for patients who suffer from debilitating diseases.